why choose us

First received: January 25, 2023

Clinical Trial: MRI Risk Maps for Prostate Cancer Diagnosis Using Targeted Biopsy

Study Status: Completed

Recruit Status: RECRUITING

Condition: Prostate Cancer

Study Type: INTERVENTIONAL


Official Title: Magnetic Resonance Imaging (MRI) Derived Quantitative Risk Maps for Prostate Cancer Diagnosis Using Targeted Biopsy

Brief Summary: Doctors leading this study hope to learn about a software that researchers at the University of Chicago have developed to help analyze radiographic images (different techniques for taking images that allow doctors to visualize the body's internal structures) of the prostate.Participation in this research will last about 12 months.There is a one-time MRI and 1-2 biopsies and then the investigator would like to follow the participant's progress.

Read more